Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01984554 · ClinicalTrials.gov registry record
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
A clinical trial, sponsored by American Regent.
- Completed
- Registry status
- 551
- Enrollment target
NCT01984554: Completed study, sponsored by American Regent.
NCT01984554 is a clinical trial that has completed, run by American Regent. The registered enrollment target is 551 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01984554 has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- 551 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-12 |
What the finished NCT01984554 record still lists
NCT01984554 is an observational study that tracks outcomes without assigning an intervention. The registered 551 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01984554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01984554 about?
NCT01984554 is a clinical study titled "Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia". The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
What is the current status of trial NCT01984554?
This trial is currently completed. The enrollment target is 551 participants. The study started on 2013-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01984554?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia